Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia

Background: We conducted a pathogenic analysis in the bronchoalveolar lavage fluid (BALF) samples from refractory Mycoplasma pneumoniae pneumonia (RMPP) children.Methods: A total of 150 BALF samples from 60 RMPP patients were analyzed to investigate pathogenic changes. The characteristics of M. pneu...

Full description

Bibliographic Details
Main Authors: Fei Zhao, Jinrong Liu, Di Xiao, Liyong Liu, Jie Gong, Juan Xu, Huimin Li, Shunying Zhao, Jianzhong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2020.553739/full
id doaj-681b0279eea5497b83dd35dc6796c61d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Fei Zhao
Jinrong Liu
Di Xiao
Liyong Liu
Jie Gong
Juan Xu
Huimin Li
Shunying Zhao
Jianzhong Zhang
spellingShingle Fei Zhao
Jinrong Liu
Di Xiao
Liyong Liu
Jie Gong
Juan Xu
Huimin Li
Shunying Zhao
Jianzhong Zhang
Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
Frontiers in Cellular and Infection Microbiology
Mycoplasma pneumoniae
refractory Mycoplasma pneumoniae pneumonia
bronchoalveolar lavage fluid
co-infection
macrolide resistant
author_facet Fei Zhao
Jinrong Liu
Di Xiao
Liyong Liu
Jie Gong
Juan Xu
Huimin Li
Shunying Zhao
Jianzhong Zhang
author_sort Fei Zhao
title Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
title_short Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
title_full Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
title_fullStr Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
title_full_unstemmed Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
title_sort pathogenic analysis of the bronchoalveolar lavage fluid samples with pediatric refractory mycoplasma pneumoniae pneumonia
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2020-10-01
description Background: We conducted a pathogenic analysis in the bronchoalveolar lavage fluid (BALF) samples from refractory Mycoplasma pneumoniae pneumonia (RMPP) children.Methods: A total of 150 BALF samples from 60 RMPP patients were analyzed to investigate pathogenic changes. The characteristics of M. pneumoniae were analyzed through culture, real-time PCR, genotyping, antimicrobial susceptibility testing and proteomics. The other pathogens were determined using culture, sequencing and nucleic acid detection.Results: In 60 RMPP cases, the bacterial co-infection rate was 5%, while that of virus was 33.3%. The poor prognosis rate was 61.7%. The DNA positive rate among the 150 samples was 98.7%, while the culture positive rate was 56.7% for M. pneumoniae. Significant differences were noticed in the positivity of M. pneumoniae culture obtained from samples with a disease course of at least 3 weeks compared with those within 3 weeks. The genotype 1 M. pneumoniae strains showed a macrolide resistant (MLr) rate of 100%, and that for genotype 2 was 90.1%. Proteomics showed that there were 57 proteins up-regulated in the MLs M. pneumoniae, half of which were membrane-associated protein with adhesion or toxicity.Conclusions: Pediatric RMPP usually presented with viral co-infection, but it caused limited effects on the progression and prognosis of RMPP. Persistent presence of viable M. pneumoniae is not necessary in the later stage of RMPP. The expression of virulence factor in the MLr M. pneumoniae was higher than that of the MLs M. pneumoniae, which was more common in the RMPP children.
topic Mycoplasma pneumoniae
refractory Mycoplasma pneumoniae pneumonia
bronchoalveolar lavage fluid
co-infection
macrolide resistant
url https://www.frontiersin.org/articles/10.3389/fcimb.2020.553739/full
work_keys_str_mv AT feizhao pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT jinrongliu pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT dixiao pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT liyongliu pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT jiegong pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT juanxu pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT huiminli pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT shunyingzhao pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
AT jianzhongzhang pathogenicanalysisofthebronchoalveolarlavagefluidsampleswithpediatricrefractorymycoplasmapneumoniaepneumonia
_version_ 1724482930338693120
spelling doaj-681b0279eea5497b83dd35dc6796c61d2020-11-25T03:52:18ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882020-10-011010.3389/fcimb.2020.553739553739Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae PneumoniaFei Zhao0Jinrong Liu1Di Xiao2Liyong Liu3Jie Gong4Juan Xu5Huimin Li6Shunying Zhao7Jianzhong Zhang8National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaDepartment of Respiratory Medicine, Beijing Children's Hospital Affiliated to Capital Medical University, National Center for Children's Health, Beijing, ChinaNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaDepartment of Respiratory Medicine, Beijing Children's Hospital Affiliated to Capital Medical University, National Center for Children's Health, Beijing, ChinaDepartment of Respiratory Medicine, Beijing Children's Hospital Affiliated to Capital Medical University, National Center for Children's Health, Beijing, ChinaNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaBackground: We conducted a pathogenic analysis in the bronchoalveolar lavage fluid (BALF) samples from refractory Mycoplasma pneumoniae pneumonia (RMPP) children.Methods: A total of 150 BALF samples from 60 RMPP patients were analyzed to investigate pathogenic changes. The characteristics of M. pneumoniae were analyzed through culture, real-time PCR, genotyping, antimicrobial susceptibility testing and proteomics. The other pathogens were determined using culture, sequencing and nucleic acid detection.Results: In 60 RMPP cases, the bacterial co-infection rate was 5%, while that of virus was 33.3%. The poor prognosis rate was 61.7%. The DNA positive rate among the 150 samples was 98.7%, while the culture positive rate was 56.7% for M. pneumoniae. Significant differences were noticed in the positivity of M. pneumoniae culture obtained from samples with a disease course of at least 3 weeks compared with those within 3 weeks. The genotype 1 M. pneumoniae strains showed a macrolide resistant (MLr) rate of 100%, and that for genotype 2 was 90.1%. Proteomics showed that there were 57 proteins up-regulated in the MLs M. pneumoniae, half of which were membrane-associated protein with adhesion or toxicity.Conclusions: Pediatric RMPP usually presented with viral co-infection, but it caused limited effects on the progression and prognosis of RMPP. Persistent presence of viable M. pneumoniae is not necessary in the later stage of RMPP. The expression of virulence factor in the MLr M. pneumoniae was higher than that of the MLs M. pneumoniae, which was more common in the RMPP children.https://www.frontiersin.org/articles/10.3389/fcimb.2020.553739/fullMycoplasma pneumoniaerefractory Mycoplasma pneumoniae pneumoniabronchoalveolar lavage fluidco-infectionmacrolide resistant